SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-20-002465
Filing Date
2020-04-07
Accepted
2020-04-07 17:49:06
Documents
1
Period of Report
2020-04-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4405
  Complete submission text file 0001171843-20-002465.txt   5832
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Issuer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 2231 LIVINGSTON NJ 07039
Business Address
Wei Binxian (Reporting) CIK: 0001773586 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33672 | Film No.: 20780601